Adverse events may or may not be caused by the treatments in the study. A lot of research is needed to know whether a treatment causes an adverse event. 

Ceralasertib by Ceralasertib and itself acalabrutinib 

How many participants had 100% (8) adverse events? 

How many participants had 75.0% (6) serious adverse events? 

How many participants stopped taking study treatment due to adverse events? 

The most common serious adverse events that happened in more than 1 participant were:
- Low red blood cell levels
- Low levels of platelets in the blood, which are cells that help blood to clot

The most common adverse events were:
- Low red blood cell levels
- Low levels of platelets in the blood, which are cells that help blood to clot
- Cough
- Diarrhea
- Fatigue
- Nausea
- Upper respiratory tract infection